Table 1.
Nanomaterial | Synthesis Method | Morphology | Size (nm) | Model | Dosage | Route of Administration | Markers | Effects | Ref. | |
---|---|---|---|---|---|---|---|---|---|---|
Powder | Hydrodynamic Radius | |||||||||
CNPs | Precipitation | Cubic | 6–16 | ND | SH-SY5Y neuroblastoma cells treated with 12.5 μM Aβ 25–35 for 24 h | 100 μg/mL for 24 h |
NA | ↑ β-TubIII, GAP43, NF-H 200 ↑ GPX1, catalase ↓ SOD1, SOD2 ↑ BDNF, TrkB ↓ p-ERK1,2 |
↑ cell viability ↓ apoptosis ↑ antioxidant response ↓ neurite atrophy ↑ neuronal differentiation Maintenance of cytoskeletal organization |
[27] |
Triphenyl phosphonium-conjugated CNPs (TPP-CNPs) |
Hydrolytic sol-gel |
ND | ND | 22 | SH-SY5Y neuroblastoma cells and U373 astrocytoma cells treated with 5 μM Aβ |
0.1 mM for 12 h |
NA | ↓mitochondrial ROS | ↓ oxidative stress | [28] |
Transgenic 5XFAD mouse as in vivo model for Alzheimer’s disease (AD) | 3 μL solution of 1 mg/mL | Unilateral subicular injection |
↓ GFAP, Iba-1 ↓ 4-HNE |
↑ neuronal viability ↓ glial cell activation ↓ oxidative stress |
||||||
CNPs modified with LXW7 peptide and polyacrylic acid (CeO2@PAA-LXW7) | EDC (1-ethyl-3-(3-dimethylaminopropyl carbodiimide) reaction |
Spherical | ND | 2–5 | Murine BV2 microglial cells | 1 μM | NA | ↓ TNFα ↓ IL-1β ↓ ROS, NO ↓ p- FAK, p-STAT3 |
↓ inflammation | [29] |
Europium doped CNPs (EuCNPs) | Solvothermal reactions | Spherical | ND | 159.06 | Murine BV2 microglial cells | 100 ng/mL | NA | ↑ CD36 ↑ co-localization of Aβ with Rab7 and LAMP1 ↓ IL-6, IL-1β |
↑ microglial phagocytosis of Aβ ↓ inflammation ↓ Aβ plaques ↓ oxidative stress ↓ Alzheimer’s disease (AD) symptoms |
[30] |
CNPs | NA (purchased) |
Spherical | ND | ND | C57BL/6J male mice exposed to PM2.5 for 6 h/day, 5 times a week for 23 weeks as in vivo model for Alzheimer’s disease (AD) | 0.25 mg/kg or 0.5 mg/kg, 1 time a week for 10 weeks |
Intravenous tail injection | ↓ IL-6, TNF-α, IL-1β ↓ NF-κBia and IκBκB ↓ GFAP ↓ ROS (O2, H2O2) ↑ SOD activity |
↓ inflammation ↓ glial cell activation ↓ oxidative stress ↑ antioxidant response |
[32] |
Mice-derived primary astrocytes treated with PM2.5 for 24 h | 5–200 ng/mL for 24 h |
NA | ↓ GFAP ↓ IL-6, TNFα, IL-1β ↓ nuclear NF-κB ↑ cytoplasmatic NF-κB ↓ COX-2 ↓ ROS (O2−, H2O2), iNOS ↑ SOD1, SOD2, NQO1 |
↓ glial cell activation ↓ inflammation ↓ oxidative stress ↑ antioxidant response |
||||||
CNPs | NA (purchased) |
ND | ND | 3.3 | SOD1G93A transgenic mouse as in vivo model for amyotrophic lateral sclerosis (ALS) | 20 mg/kg, 2 times a week |
Intravenous tail injection | ↑ muscle strength ↑ survival (+11 days ca.) ↓ clinical score ↓ body weight loss |
[33] | |
CNPs | NA (purchased) |
Spherical | 3–5 | ND | Wistar rats exposed to unpredictable chronic mild stress (UCMS) as in vivo model for stress-induced depression | 10 nM | Intrahippocampal and intracerebroventricular injection | ↓ IL-6 ↓ MDA ↑ GAP-43+ neurons ↑ CA3 neurons number |
↓ depressive-like behavior ↓ inflammation ↓ oxidative stress ↑ neurogenesis ↑ neurite outgrow |
[35] |
CNPs | Reverse micelle | Spherical | 3.5 ± 0.5 | ND | VC57BL/6J male mice exposed to open head injury using a stereotaxic impactor as in vivo model for traumatic brain injury (TBI) | 11.6 mM | Retro-orbital injection | ↓ FJB+ and TUNEL+ cells ↑ SOD1 and SOD2 mRNA ↓ COX-2 |
↓ neuronal cell death ↓ oxidative stress ↓ inflammation ↑ cognitive functions ↓ cerebral edema |
[36] |
Hydrothermal | Rods | 9.4 ± 2.1 Length: 130.1 ± 42.1 |
ND |
CNPs: cerium oxide nanoparticles; ROS: reactive oxygen species; A β: amyloid-beta; β-TubIII: beta-tubulin III; GAP-43: growth-associated protein 43; NF-H200: neurofilament 200; SOD: superoxide dismutase; BDNF: brain-derived neurotrophic factor; TrkB: BNDF receptor; GPX: glutathione peroxidase; p-ERK: phospho- extracellular signal-regulated kinase; GFAP: glial fibrillary acidic protein; Iba-1: ionized calcium-binding adapter molecule 1; 4-HNE: 4-hydroxynonenal; IL: interleukin; TNF-α: tumor necrosis factor-alpha; p-NF-κB: phospho-nuclear factor kappa-light-chain-enhancer of activated B cells; COX: cyclooxygenase; iNOS: inducible nitric oxide synthase; NQO1: NAD(P)H quinone dehydrogenase 1; NADPH: nicotinamide adenine dinucleotide phosphate; MDA: mondialdehyde; GAP-43: growth-associated Protein 43; CA3: hippocampal region; FJB: fluoro-jade B staining; FAK: focal adhesion kinase; STAT3: transducer and activator of transcription 3; CD36: cluster of differentiation 36; Rab7: Ras-related protein 7; LAMP1: lysosomal-associated membrane protein 1; NA: not applicable; ND: not determined. Colored areas highlight in vivo experiments.